Have a personal or library account? Click to login
Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma Cover

Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma

Open Access
|Apr 2009

Abstract

Background. Cisplatin, a widely used antineoplastic agent usually induces peripheral neuropathy, but can rarely also complicate with encephalopathy, with or without seizures.

Case report. We report a case of a young patient with metastatic malignant melanoma with signs and symptoms of cisplatin-induced non-convulsive posterior reversible encephalopaty syndrome. Within the days shortly after the first cycle of cisplatin based chemotherapy the patient suffered from nausea, vomitus, headache, severe pain at the site of sub-cutaneous metastases and confusion. She later experienced somnolence, cortical blindness and aphasia, but without epileptic seizures.

Conclusions. Cisplatin is an effective chemotherapeutic drug but also very toxic one and physicians using it must also be aware of possible encephalopathy.

DOI: https://doi.org/10.2478/v10019-009-0005-0 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 120 - 125
Published on: Apr 2, 2009
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Janja Ocvirk, Marko Boc, Martina Rebersek, Tanja Ros, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 2 (June 2009)